Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three months ended March 31, 2026
Filing Date: May 14, 2026
Principal Executive Offices: Vancouver, British Columbia, Canada
This filing serves as a cover document submitting unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis (MD&A) for the quarter ended March 31, 2026.
Key Financial Metrics
The provided text contains only the cover page and exhibit list of the Form 6-K. It does not include the actual financial statements or MD&A content.
- Revenue: Not provided in source text.
- Profit/Loss: Not provided in source text.
- Cash Flow: Not provided in source text.
- Margins: Not provided in source text.
- Debt and Liquidity: Not provided in source text.
Material Changes
The filing text does not provide specific data to compare against prior periods. Material changes, if any, would be detailed in the attached Exhibit 99.2 (MD&A), which is not included in the input.
Guidance, Outlook, and Risks
No management commentary, forward-looking guidance, risk factors, or contingencies are present in the provided cover page text. These disclosures are expected to be found in the referenced Exhibit 99.2.
Investor Verification Checklist
- Verify the actual financial performance (revenue, net income, cash position) by reviewing Exhibit 99.1 (Unaudited Interim Condensed Consolidated Financial Statements).
- Review Exhibit 99.2 (MD&A) for management's explanation of results, liquidity analysis, and risk factors.
- Confirm the company's filing status as a foreign private issuer under Form 40-F as indicated in the cover page.
- Check for any subsequent events or updates between the period end (March 31, 2026) and the filing date (May 14, 2026) in the full MD&A.